ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

First Treatment for Breast Cancer with certain Inherited Gene Mutation

Journal: Scientific Journal of Genetics and Gene Therapy (Vol.4, No. 1)

Publication Date:

Authors : ;

Page : 001-001

Keywords : ;

Source : Downloadexternal Find it from : Google Scholarexternal

Abstract

The U.S. Food and Drug Administration approved use of Lynparza (olaparib tablets) treat certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer.

Last modified: 2019-01-10 21:12:50